LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
  • Should you invest £1,000 in AstraZeneca right now?

    When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

    And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if AstraZeneca made the list?

    See the 6 stocks

  • AstraZeneca PLC (LSE: AZN) Latest News

    Investing Articles

    If I’d put £10,000 into the FTSE 100’s biggest stock at the start of 2024, here’s what I’d have now

    The FTSE 100’s biggest company has romped away from the index over the last five years, but has fallen behind…

    Read more »

    Arrow symbol glowing amid black arrow symbols on black background.
    Investing Articles

    As AstraZeneca’s share price drops 11%, does the stock look an unmissable bargain to me?

    AstraZeneca’s share price has fallen 11%, leaving it looking even more of a bargain to me than before, supported by…

    Read more »

    Dividend Shares

    Here are the 2025 dividend forecasts for FTSE giants Unilever, GSK, and AstraZeneca

    These FTSE shares don’t have the highest yields. But Edward Sheldon believes they could deliver attractive returns in the years…

    Read more »

    Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
    Investing Articles

    I wish I’d known about this profitable stock market investing strategy 10 years ago

    Long-term data suggests this investment approach yields returns that surpass the performance of major stock market indexes.

    Read more »

    Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
    Investing Articles

    2 of my favourite FTSE 100 shares have just plunged 12% and 10%! Time to buy?

    Harvey Jones is in bargain-hunting mode and wondering if these two FTSE 100 shares could make exciting purchases after falling…

    Read more »

    Abstract bull climbing indicators on stock chart
    Investing Articles

    As AstraZeneca’s share price drops 13% should I buy on the dip?

    AstraZeneca’s share price has fallen following unfavourable results for one of its new drugs, but others look good, and earnings…

    Read more »

    Young woman holding up three fingers
    Investing Articles

    3 stunning FTSE 100 shares I plan to buy in October 

    Our writer identifies three stocks on the FTSE 100 he feels would add the variety of growth, income and stability…

    Read more »

    Investing Articles

    This UK stock looks pretty cheap to me

    This Fool is always on the hunt for value, and with plenty of potential for growth, this UK stock ticks…

    Read more »

    Edinburgh Cityscape with fireworks over The Castle and Balmoral Clock Tower
    Investing Articles

    My favourite UK share on the entire LSE has fallen 5% in a week! Time to buy?

    Harvey Jones has waited for years to buy this brilliant UK share. Has the recent stock market dip finally handed…

    Read more »

    Investing Articles

    FTSE 100 investors should pay attention to these 4 things in September 2024

    Charlie Carman explores four key factors for UK investors to monitor this month that will influence the future direction of…

    Read more »

    Investing Articles

    4 stocks that might power the FTSE 100 towards 10,000

    The FTSE 100 has been flirting with its all-time high again. Could it break through and hit that magical 10,000…

    Read more »

    Investing Articles

    As AstraZeneca reaches a 52-week high, is this still a top UK stock to consider?

    Ben McPoland takes a look at the largest UK stock by market cap to assess whether it might be overvalued…

    Read more »